Milk-derived GM(3) and GD(3) differentially inhibit dendritic cell maturation and effector functionalities

H. Bronnum, T. Seested, Lars Hellgren, Susanne Brix Pedersen, H. Frokiaer

    Research output: Contribution to journalJournal articleResearchpeer-review


    Gangliosides are complex glycosphingolipids, which exert immune-modulating effects on various cell types. Ganglioside GD(3) and GM(3) are the predominant gangliosides of human breast milk but during the early phase of lactation, the content of GD(3) decreases while GM(3) increases. The biological value of gangliosides in breast milk has yet to be elucidated but when milk is ingested, dietary gangliosides might conceptually affect immune cells, such as dendritic cells (DCs). In this study, we address the in vitro effect of GD(3) and GM(3) on DC effector functionalities. Treatment of bone marrow-derived DCs with GD(3) before lipopolysaccharide-induced maturation decreased the production of interleukin-6 (IL-6), IL-10, IL-12 and tumor necrosis factor-alpha as well as reduced the alloreactivity in mixed leucocyte reaction (MLR). In contrast, only IL-10 and IL-12 productions were significantly inhibited by GM(3,) and the potency of DCs to activate CD4(+) cells in MLR was unaffected by GM(3). However, both gangliosides suppressed expression of CD40, CD80, CD86 and major histocompatibility complex class II on DCs. Because GD(3) overall inhibits DC functionalities more than GM(3), the immune modulating effect of the ganglioside fraction of breast milk might be more prominent in the commencement of lactation during which the milk contains the most GD(3).
    Original languageEnglish
    JournalScandinavian Journal of Immunology
    Issue number6
    Pages (from-to)551-557
    Publication statusPublished - 2005

    Fingerprint Dive into the research topics of 'Milk-derived GM(3) and GD(3) differentially inhibit dendritic cell maturation and effector functionalities'. Together they form a unique fingerprint.

    Cite this